Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical Expects FY2024 Sales Of $49.7M-$52.9M Versus Consensus Of $60.18M, With Net Loss Of $(26.5)M-$(24.3)M
Apyx Medical 预计 FY2024 的销售额为4,970万至5,290万美元，而市场预期为6,018万美元，净亏损为2650万美元（2430万美元）
- Total revenue guidance assumes:
- Advanced Energy revenue in the range of $41.6 million to $44.6 million, representing a decrease of approximately 4% to growth of approximately 3% year-over-year, compared to Advanced Energy revenue of $43.4 million for the year ended December 31, 2023.
- OEM revenue in the range of $8.1 million to $8.3 million, representing a decrease of 10% to 7% year-over-year, compared to $9.0 million for the year ended December 31, 2023.
- 总收入指导假设：
- 先进能源收入在4,160万美元至4,460万美元之间，同比下降约4％，同比增长约3％，而截至2023年12月31日的年度先进能源收入为4,340万美元。
- 原始设备制造商收入在810万美元至830万美元之间，与截至2023年12月31日止年度的900万美元相比，同比下降10％至7％。